RE: How much is a biotech with no approved drugs worth? Billions, NantKwest investors say (Elie Kobrin, 29 Jul 2015)GPACU and GLBL (Vahe Stepanian, 29 Jul 2015)
Case Fileefta-efta00850136DOJ Data Set 9FW: *** NEW JOINT BOOKRUN INITIAL PUBLIC OFFERING *** POSEIDON (Vahe Stepanian, 29 Jul 2015)
Unknown2p
Case File
efta-efta00850136DOJ Data Set 9FW: *** NEW JOINT BOOKRUN INITIAL PUBLIC OFFERING *** POSEIDON (Vahe Stepanian, 29 Jul 2015)
Other
From: Vahe Stepanian. To: jeffrey E. Date: 29 Jul 2015. Subject: FW: *** NEW JOINT BOOKRUN INITIAL PUBLIC OFFERING *** POSEIDON
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00850136
Pages
2
Persons
0
Integrity
Loading document viewer...
Forum Discussions
Advertisement
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.